Reduced Presynaptic Dopamine Activity in Fibromyalgia Syndrome Demonstrated With Positron Emission Tomography: A Pilot Study

229Citations
Citations of this article
158Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Although the pathophysiology underlying the pain of fibromyalgia syndrome (FMS) remains unknown, a variety of clinical and investigational findings suggests a dysregulation of dopaminergic neurotransmission. We therefore investigated presynaptic dopaminergic function in 6 female FMS patients in comparison to 8 age- and gender-matched controls as assessed by positron emission tomography with 6-[18F]fluoro-L-DOPA as a tracer. Semiquantitative analysis revealed reductions in 6-[18F]fluoro-L-DOPA uptake in several brain regions, indicating a disruption of presynaptic dopamine activity wherein dopamine plays a putative role in natural analgesia. Although the small sample size makes these findings preliminary, it appears that FMS might be characterized by a disruption of dopaminergic neurotransmission. Perspective: An association between FMS and reduced dopamine metabolism within the pain neuromatrix provides important insights into the pathophysiology of this mysterious disorder. © 2007 American Pain Society.

Cite

CITATION STYLE

APA

Wood, P. B., Patterson, J. C., Sunderland, J. J., Tainter, K. H., Glabus, M. F., & Lilien, D. L. (2007). Reduced Presynaptic Dopamine Activity in Fibromyalgia Syndrome Demonstrated With Positron Emission Tomography: A Pilot Study. Journal of Pain, 8(1), 51–58. https://doi.org/10.1016/j.jpain.2006.05.014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free